Bargain hunters can buy CPRX at a price even lower than Muth did, with the stock trading as low as $2.50 at last check today which is 5.7% under Muth’s purchase price. Catalyst Pharmaceutical Partners is trading up …
A total number of 3 were posted for Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), as of 2016-06-25, as per the ClosingBell Active Analyst Ratings. The stock also carries an average rating of 4. It should be noted …
/EIN News/ -- Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, will visit the Nasdaq …
Analysts are weighing in on biotech stock Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), fiber-optics expert Applied Optoelectronics Inc (NASDAQ:AAOI), and medical device maker BioTelemetry, Inc. (NASDAQ:BEAT). …
Analyst
Displaying a price of $1.12, Catalyst Pharma (NASDAQ:CPRX) traded 28.57% higher on the day. The last …
Stock-Callers.com today presents the following Generic Drugs equities for assessment: Catalyst …
The Business
according to ShortSqueeze.com. Any encouraging news from Martha Stewart Living could lead to a wave of short sellers trying to buy stock and limit their losses, pushing the price higher. - CNBC / MSN Money ...short …
Stock
On September 30, 2016, the Company received a notice from The NASDAQ Stock Market (“NASDAQ”) confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing …
CPRX)'s market cap, the total dollar value of all of their outstanding shares, is 128.60m. The current share price indicate that stock is 0.62% away …
Canada Goose